Enzymotec Ltd. to Participate in the 16th Annual ICR XChange Conference

MIGDAL HA'EMEQ, Israel, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Chief Financial Officer, will present at the 16th Annual ICR XChange Conference on Monday, January 13, 2014 at 10:00 a.m. ET in Orlando, FL.

The audio portion of Enzymotec's presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at www.enzymotec.com.

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-functional lipid ingredients, as well as final products, based on sophisticated processes and technologies. For more information, visit www.enzymotec.com.

CONTACT: ICR, LLC Katie Turner 646-277-1228 -or- John Mills 310-954-1105 John.Mills@icrinc.comSource:Enzymotec Ltd.